{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:14:23Z","timestamp":1783415663730,"version":"3.54.6"},"reference-count":35,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"ABOARD","award":["73305095007"],"award-info":[{"award-number":["73305095007"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Research into Alzheimer\u2019s disease has primarily focused on clinical cohorts, yet many patients are diagnosed and followed in primary care. An infrastructure comprising routinely collected and linked electronic health records from primary care, hospitals, and pharmacies, i.e., real-world data (RWD), can provide insight into disease trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aim to describe the ABOARD-RWD infrastructure, focusing on its design, data sources, representativeness, and potential applications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The ABOARD-RWD infrastructure includes 79,114 Dutch adults with incident dementia (2011\u20132022), identified through dementia diagnoses, free-text mentions, or use of dementia-related drugs. Linked data includes general practitioner (GP), hospital care, outpatient pharmacy, laboratories, and specialized registries. Descriptive analyses assessed demographics, prevalence, and clinical characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The ABOARD-RWD Infrastructure (age 81\u2009\u00b1\u20099, 59% female) has a median 8.6-year look-back period (IQR 4.7\u201312.3) and 2.2-year follow-up (IQR 0.9\u20134.2) from first dementia diagnosis. Dementia was recorded in GP for 86%, hospitals for 34%, and 22% received dementia-related drugs. Dementia prevalence in 2022 was 9.3 per 1,000 (10.9 women, 7.6 men), aligning with national estimates. Mini-Mental State Examinations were recorded for 62%: 35% scored \u226524, 26% scored 18\u201323, 13% scored &lt;18, and 25% had an unknown score. Cardiovascular disease was recorded in 48%, hypertension in 51%, diabetes in 23%, hypercholesterolemia in 19%, cerebrovascular disease in 20%, asthma\/chronic obstructive pulmonary disease in 14%, psychiatric conditions in 17%, and sleep disturbances in 13%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The ABOARD-RWD Infrastructure enables real-world, longitudinal dementia research across multiple healthcare settings. It captures representative patient journeys, supporting studies on risk factors, diagnosis, management, and outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13872877261429858","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:04:41Z","timestamp":1774879481000},"page":"157-166","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["The ABOARD-RWD infrastructure: Using linked real-world data to study the diagnosis and management of dementia"],"prefix":"10.1177","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-2462","authenticated-orcid":false,"given":"Brenda N.","family":"Baak","sequence":"first","affiliation":[{"name":"PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands"},{"name":"Vrije Universiteit Amsterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"de Boer","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam"},{"name":"Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands"},{"name":"Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, the Netherlands"},{"name":"Amsterdam Public Health, Methodology, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Nooralishahi","sequence":"additional","affiliation":[{"name":"Medisch Centrum Mediport, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine E. A.","family":"Adolfsen","sequence":"additional","affiliation":[{"name":"PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Lemmens","sequence":"additional","affiliation":[{"name":"PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argonde C.","family":"van Harten","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam"},{"name":"Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Everard G. B.","family":"Vijverberg","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam"},{"name":"Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiesje M.","family":"van der Flier","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Amsterdam"},{"name":"Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands"},{"name":"Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, the Netherlands"},{"name":"Amsterdam Public Health, Methodology, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron M. C.","family":"Herings","sequence":"additional","affiliation":[{"name":"PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands"},{"name":"Pharmacoepidemiology &amp; Health Care Optimization, Department of Epidemiology &amp; Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"e_1_3_4_2_2","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022; 7: e105\u2013e125.","journal-title":"Lancet Public Health"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100096"},{"key":"e_1_3_4_5_2","article-title":"Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease)","volume":"9","author":"Dreves MAE","year":"2023","unstructured":"Dreves MAE, van Harten AC, Visser LNC, et al. Rationale and design of the ABOARD project (A Personalized Medicine Approach for Alzheimer's Disease). Alzheimers Dement (N Y) 2023; 9: e12401.","journal-title":"Alzheimers Dement (N Y)"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S247575"},{"key":"e_1_3_4_7_2","unstructured":"Dutch Hospital Data Foundation. (https:\/\/www.dhd.nl)."},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","unstructured":"Kuiper JG van Herk-Sukel MPP Lemmens V et al. A population-based linked cohort of cancer and primary care data: A new source to study the management of cancer in primary care. Eur J Cancer Care (Engl) 2022: e13529.","DOI":"10.1111\/ecc.13529"},{"key":"e_1_3_4_9_2","unstructured":"Netherlands Comprehensive Cancer Organisation. (https:\/\/www.iknl.nl\/nkr)."},{"key":"e_1_3_4_10_2","unstructured":"PALGA Foundation. (http:\/\/www.palga.nl)."},{"key":"e_1_3_4_11_2","unstructured":"International Classification of Primary Care. (https:\/\/www.nhg.org\/themas\/artikelen\/icpc)."},{"key":"e_1_3_4_12_2","unstructured":"WHO Anatomical Therapeutic Chemical Classification System. (http:\/\/www.whocc.no\/atc_ddd_index)."},{"key":"e_1_3_4_13_2","unstructured":"Dutch WCIA Coding System. (http:\/\/aut.nhg.org\/labcodeviewer\/)."},{"key":"e_1_3_4_14_2","unstructured":"WHO International Classification of Diseases. (http:\/\/www.who.int\/classifications\/icd\/en\/)."},{"key":"e_1_3_4_15_2","unstructured":"Dutch Hospital Data Foundation registration system for procedures. (https:\/\/www.dhd.nl\/producten-diensten\/verrichtingenbestand\/Paginas\/Verrichtingenbestand.aspx)."},{"key":"e_1_3_4_16_2","unstructured":"Nivel. Register Dementiezorg en Ondersteuning: Factsheet 7 \u2013Achtergrondkenmerken van mensen met dementie https:\/\/www.nivel.nl\/sites\/default\/files\/bestanden\/1004087_0.pdf (2021)."},{"key":"e_1_3_4_17_2","unstructured":"Sociaal en Cultureel Planbureau. (http:\/\/www.scp.nl)."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_3_4_19_2","unstructured":"Ministry of Health Netherlands. Dementie: Leeftijd en geslacht. https:\/\/www.vzinfo.nl\/dementie\/leeftijd-en-geslacht (2022 accessed March 23 2025)."},{"key":"e_1_3_4_20_2","unstructured":"Heide I van der Veer A de Verheij R et al. Cijfers over 2019 2018 en 2017 uit het landelijke Register Dementiezorg en Ondersteuning. Factsheet 7 \u2013 Achtergrondkenmerken van mensen met dementie. Nivel. (2021)."},{"key":"e_1_3_4_21_2","unstructured":"Vektis Intelligence. Factsheet dementie. https:\/\/www.vektis.nl\/intelligence\/publicaties\/factsheet-dementie (2022 accessed March 23 2025)."},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afab164"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04196-7"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1947"},{"key":"e_1_3_4_25_2","unstructured":"Alzheimer Europe. Dementia in Europe Yearbook 2019: Estimating the prevalence of dementia in Europe https:\/\/www.alzheimer-europe.org\/sites\/default\/files\/alzheimer_europe_dementia_in_europe_yearbook_2019.pdf (2019 accessed December 19 2025)."},{"key":"e_1_3_4_26_2","first-page":"69","article-title":"The validity of national hospital discharge register data on dementia: a comparative analysis using clinical data from a university medical centre","volume":"73","author":"van de Vorst IE","year":"2015","unstructured":"van de Vorst IE, Vaartjes I, Sinnecker LF, et al. The validity of national hospital discharge register data on dementia: a comparative analysis using clinical data from a university medical centre. Neth J Med 2015; 73: 69\u201375.","journal-title":"Neth J Med"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.016"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S389598"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01768-6"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cb3e25"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3233\/ADR-210005"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170850"},{"key":"e_1_3_4_33_2","article-title":"European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol","volume":"8","author":"Solomon A","year":"2019","unstructured":"Solomon A, Kivipelto M, Molinuevo JL, et al. European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol. BMJ Open 2019; 8: e021017.","journal-title":"BMJ Open"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116538"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-023-00404-2"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01725-7"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261429858","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877261429858","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877261429858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:24:43Z","timestamp":1783412683000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877261429858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/13872877261429858"],"URL":"https:\/\/doi.org\/10.1177\/13872877261429858","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}